EFSD "New Targets for Diabetes or Obesity-related Metabolic Diseases"

supported by an educational research grant from MSD

2023

Emma Ahlqvist: Lund University - Sweden
A translational approach to identification of novel targets for treatment of diabetes and muscle insulin-resistance

Jorge Ferrer: Barcelona Institute for Science and Technology - Spain
Development of a multiomics platform to unravel beta-cell regulatory networks in type 2 diabetes

Johan Jonker: University Medical Center Groningen - Netherlands
Role of a novel triglyceride synthesis pathway (TMX1/DIESL) in lipotoxicity and insulin resistance

2022

Sophie Steculorum: Max Planck Institute for Metabolism Research - Cologne, Germany
Unravelling the role of lipid metabolism in the main olfactory epithelium in obesity and obesity-related diseases

Ingrid Wernstedt-Asterholm: University of Gothenburg - Sweden
Collagen fragments in the regulation of adipose tissue remodelling

Anja Zeigerer: Helmholtz Munich, Institute for Diabetes and Cancer - Germany
Investigating the transcriptional control of Vps37a as a new target for the treatment of type 2 diabetes

2021

Quan Zhang: University of Oxford - UK
Metabolic memory of islet delta cells in defective glucagon secretion in recurrent hypoglycaemia

Amelie Bonnefond: Inserm UMR1283 - Lille, France
Opioid receptor delta and POMC: new potential targets for enhancing insulin secretion